Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

ATXN2 trinucleotide repeat length correlates with risk of ALS.

Sproviero W, Shatunov A, Stahl D, Shoai M, van Rheenen W, Jones AR, Al-Sarraj S, Andersen PM, Bonini NM, Conforti FL, Van Damme P, Daoud H, Del Mar Amador M, Fogh I, Forzan M, Gaastra B, Gellera C, Gitler AD, Hardy J, Fratta P, La Bella V, Le Ber I, Van Langenhove T, Lattante S, Lee YC, Malaspina A, Meininger V, Millecamps S, Orrell R, Rademakers R, Robberecht W, Rouleau G, Ross OA, Salachas F, Sidle K, Smith BN, Soong BW, Sorarù G, Stevanin G, Kabashi E, Troakes C, van Broeckhoven C, Veldink JH, van den Berg LH, Shaw CE, Powell JF, Al-Chalabi A.

Neurobiol Aging. 2016 Nov 24. pii: S0197-4580(16)30297-4. doi: 10.1016/j.neurobiolaging.2016.11.010. [Epub ahead of print]

2.

Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials?

Atassi N, Beghi E, Blanquer M, Boulis NM, Cantello R, Caponnetto C, Chiò A, Dunnett SB, Feldman EL, Vescovi A, Mazzini L; attendees of the International Workshop on Progress in Stem Cells Research for ALS/MND..

Cytotherapy. 2016 Dec;18(12):1471-1475. doi: 10.1016/j.jcyt.2016.08.005.

PMID:
27720637
3.

TBK1 is associated with ALS and ALS-FTD in Sardinian patients.

Borghero G, Pugliatti M, Marrosu F, Marrosu MG, Murru MR, Floris G, Cannas A, Occhineri P, Cau TB, Loi D, Ticca A, Traccis S, Manera U, Canosa A, Moglia C, Calvo A, Barberis M, Brunetti M, Gibbs JR, Renton AE, Errichiello E, Zoledziewska M, Mulas A, Qian Y, Din J, Pliner HA, Traynor BJ, Chiò A; ITALSGEN and SARDINALS Consortia..

Neurobiol Aging. 2016 Jul;43:180.e1-5. doi: 10.1016/j.neurobiolaging.2016.03.028.

PMID:
27156075
4.

REM sleep behavior disorder and periodic leg movements during sleep in ALS.

Lo Coco D, Puligheddu M, Mattaliano P, Congiu P, Borghero G, Fantini ML, La Bella V, Ferri R.

Acta Neurol Scand. 2017 Feb;135(2):219-224. doi: 10.1111/ane.12593.

PMID:
27027974
5.

ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion.

Chiò A, Mora G, Sabatelli M, Caponnetto C, Lunetta C, Traynor BJ, Johnson JO, Nalls MA, Calvo A, Moglia C, Borghero G, Trojsi F, La Bella V, Volanti P, Simone I, Salvi F, Logullo FO, Riva N, Carrera P, Giannini F, Mandrioli J, Tanel R, Capasso M, Tremolizzo L, Battistini S, Murru MR, Origone P, Zollino M, Penco S; ITALSGEN consortium.; SARDINIALS consortium., Mazzini L, D'Alfonso S, Restagno G, Brunetti M, Barberis M, Conforti FL.

Neurobiol Aging. 2016 Mar;39:218.e5-8. doi: 10.1016/j.neurobiolaging.2015.11.027.

PMID:
26733254
6.

Plasma cortisol level in amyotrophic lateral sclerosis.

Spataro R, Volanti P, Vitale F, Meli F, Colletti T, Di Natale A, La Bella V.

J Neurol Sci. 2015 Nov 15;358(1-2):282-6. doi: 10.1016/j.jns.2015.09.011.

PMID:
26384616
7.

Reply to Dr Michaud et al.

Elia AE, Viscomi C, La Bella V, Tedeschi G, Albanese A.

Eur J Neurol. 2015 Sep;22(9):e78. doi: 10.1111/ene.12756. No abstract available.

PMID:
26278108
8.

Bilateral Iatrogenic Femoral Neuropathy.

Bono V, La Bella V, Spataro R.

J Clin Neurol. 2015 Oct;11(4):398-9. doi: 10.3988/jcn.2015.11.4.398. No abstract available.

9.

HFE p.H63D polymorphism does not influence ALS phenotype and survival.

Chiò A, Mora G, Sabatelli M, Caponnetto C, Lunetta C, Traynor BJ, Johnson JO, Nalls MA, Calvo A, Moglia C, Borghero G, Monsurrò MR, La Bella V, Volanti P, Simone I, Salvi F, Logullo FO, Nilo R, Giannini F, Mandrioli J, Tanel R, Murru MR, Mandich P, Zollino M, Conforti FL, Penco S; ITALSGEN consortium.; SARDINIALS consortium., Brunetti M, Barberis M, Restagno G.

Neurobiol Aging. 2015 Oct;36(10):2906.e7-11. doi: 10.1016/j.neurobiolaging.2015.06.016.

10.
11.

The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.

Tramacere I, Dalla Bella E, Chiò A, Mora G, Filippini G, Lauria G; EPOS Trial Study Group..

J Neurol Neurosurg Psychiatry. 2015 Nov;86(11):1180-5. doi: 10.1136/jnnp-2014-310176.

PMID:
25886781
12.

CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients.

Chiò A, Mora G, Sabatelli M, Caponnetto C, Traynor BJ, Johnson JO, Nalls MA, Calvo A, Moglia C, Borghero G, Monsurrò MR, La Bella V, Volanti P, Simone I, Salvi F, Logullo FO, Nilo R, Battistini S, Mandrioli J, Tanel R, Murru MR, Mandich P, Zollino M, Conforti FL; ITALSGEN Consortium., Brunetti M, Barberis M, Restagno G, Penco S, Lunetta C.

Neurobiol Aging. 2015 Apr;36(4):1767.e3-6. doi: 10.1016/j.neurobiolaging.2015.01.017.

13.

Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis.

Elia AE, Lalli S, Monsurrò MR, Sagnelli A, Taiello AC, Reggiori B, La Bella V, Tedeschi G, Albanese A.

Eur J Neurol. 2016 Jan;23(1):45-52. doi: 10.1111/ene.12664.

14.

Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study.

Lauria G, Dalla Bella E, Antonini G, Borghero G, Capasso M, Caponnetto C, Chiò A, Corbo M, Eleopra R, Fazio R, Filosto M, Giannini F, Granieri E, La Bella V, Logroscino G, Mandrioli J, Mazzini L, Monsurrò MR, Mora G, Pietrini V, Quatrale R, Rizzi R, Salvi F, Siciliano G, Sorarù G, Volanti P, Tramacere I, Filippini G; EPOS Trial Study Group..

J Neurol Neurosurg Psychiatry. 2015 Aug;86(8):879-86. doi: 10.1136/jnnp-2014-308996.

15.

MTHFR C677T allelic variant is not associated with plasma and cerebrospinal fluid homocysteine in amyotrophic lateral sclerosis.

Bellia C, Bivona G, Caruso A, Elce A, Amato F, Spataro R, Colletti T, Pivetti A, Russo V, Scazzone C, Lo Sasso B, Castaldo G, La Bella V, Ciaccio M.

Clin Chem Lab Med. 2015 Feb;53(3):e73-5. doi: 10.1515/cclm-2014-0465. No abstract available.

PMID:
25229416
16.

Paraneoplastic motor neuron disease associated with breast cancer.

Spataro R, La Bella V.

Eur J Neurol. 2014;21(1):e5-6. doi: 10.1111/ene.12295. No abstract available.

PMID:
25133280
17.

A case of amyotrophic lateral sclerosis with intermediate ATXN-1 CAG repeat expansion in a large family with spinocerebellar ataxia type 1.

Spataro R, La Bella V.

J Neurol. 2014 Jul;261(7):1442-3. doi: 10.1007/s00415-014-7400-1. No abstract available.

PMID:
24916831
18.

Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis.

Johnson JO, Pioro EP, Boehringer A, Chia R, Feit H, Renton AE, Pliner HA, Abramzon Y, Marangi G, Winborn BJ, Gibbs JR, Nalls MA, Morgan S, Shoai M, Hardy J, Pittman A, Orrell RW, Malaspina A, Sidle KC, Fratta P, Harms MB, Baloh RH, Pestronk A, Weihl CC, Rogaeva E, Zinman L, Drory VE, Borghero G, Mora G, Calvo A, Rothstein JD; ITALSGEN Consortium., Drepper C, Sendtner M, Singleton AB, Taylor JP, Cookson MR, Restagno G, Sabatelli M, Bowser R, Chiò A, Traynor BJ.

Nat Neurosci. 2014 May;17(5):664-6. doi: 10.1038/nn.3688.

19.

Expression of vesicle-associated membrane-protein-associated protein B cleavage products in peripheral blood leukocytes and cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis.

Deidda I, Galizzi G, Passantino R, Cascio C, Russo D, Colletti T, La Bella V, Guarneri P.

Eur J Neurol. 2014 Mar;21(3):478-85. doi: 10.1111/ene.12334.

PMID:
24372953
20.

The eye-tracking computer device for communication in amyotrophic lateral sclerosis.

Spataro R, Ciriacono M, Manno C, La Bella V.

Acta Neurol Scand. 2014 Jul;130(1):40-5. doi: 10.1111/ane.12214.

PMID:
24350578
Items per page

Supplemental Content

Loading ...
Support Center